Measuring HIV Neutralization in a Luciferase Reporter Gene Assay (original) (raw)

References

  1. Wyatt, R., Sodroski, J. (1998) The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280, 1884–1888.
    Article CAS PubMed Google Scholar
  2. Lasky, L. A., Nakamura, G., Smith, D. H., et al. (1987) Delineation of a region of the human immunodeficiency virus gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 50, 975–985.
    Article CAS PubMed Google Scholar
  3. Berger, E. A. (1997) HIV entry and tropism: the chemokine receptor connection. AIDS 11(suppl. A), S3–S16.
    PubMed Google Scholar
  4. Berger, E. A., Doms, R. W., Fenyö, E.-M., et al. (1998) A new classification for HIV-1. Nature 391, 240.
    Article CAS PubMed Google Scholar
  5. Weissenhorn, W., Dessen, A., Harrison, S. C., et al. (1997) Atomic structure of the ectodomain from HIV-1 gp41. Nature 387, 426–430.
    Article CAS PubMed Google Scholar
  6. Chan, D. C., Fass, D., Berger, J. M., et al. (1997) Core structure of gp41 from the HIV envelope glycoprotein. Cell 89, 263–273.
    Article CAS PubMed Google Scholar
  7. Chan, D. C., Kim, P. S. (1998) HIV entry and its inhibition. Cell 93, 681–684.
    Article CAS PubMed Google Scholar
  8. Salzwedel, K., Smith, E. D., Dey, B., et al. (2000) Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120. J. Virol. 74, 326–333.
    Article CAS PubMed Google Scholar
  9. McDougal, J. S., Kennedy, M. S., Orloff, S. L., et al. (1996) Mechanism of human immunodeficiency virus type 1 (HIV-1) neutralization: irreversible inactivation of infectivity by anti-HIV-1 antibody. J. Virol. 70, 5236–5245.
    CAS PubMed Google Scholar
  10. Sullivan, N., Sun, Y., Sattentau, Q., et al. (1998) CD4-induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. J. Virol. 72, 4694–4703.
    CAS PubMed Google Scholar
  11. Wei, X., Decker, J. M., Wang, S., et al. (2003) Antibody neutralization and escape. Nature 422, 307–312.
    Article CAS PubMed Google Scholar
  12. Platt, E. J., Wehrly, K., Kuhmann, S. E., et al. (1998) Effects of CCR5 and CD4 cell surface concentrations on infection by macrophage tropic isolates of human immunodeficiency virus type 1. J. Virol. 72, 2855–2864.
    CAS PubMed Google Scholar
  13. Wei, X., Decker, J. M., Liu, H., et al. (2002) Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother. 46, 1896–1905.
    Article CAS PubMed Google Scholar
  14. Leitner, T., Korber, B., Daniels, M., et al. (2005) HIV-1 subtype and circulating recombinant form (CRF) reference sequences, 2005. in (T. Leitner, B. Foley, B. Hahn, P. Marx, F. McCutchan, J. W. Mellors, S. Wolinski, and B. Korber eds.), HIV Sequence Compendium 2005, pp. 41–48. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, N. Mex. (http://hiv.lanl.gov).
    Google Scholar
  15. Kwong, P. D., Doyle, M. L., Casper, D. J., et al. (2002) HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 420, 678–682.
    Article CAS PubMed Google Scholar
  16. Richman, D. D., Wrin, T., Little, S. J. et al. (2003) Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. (USA) 100, 4144–4149.
    Article CAS Google Scholar
  17. Haynes, B. F, Montefiori, D. C. (2006) Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates. Expert Rev. Vaccines 5, 347–363.
    Article CAS PubMed Google Scholar
  18. Mascola, J. R., D’Souza, P., Gilbert, P., et al. (2005) Recommendations for the design and use of standard virus panels to assess the neutralizing antibody response elicited by candidate human immunodeficiency virus type 1 vaccines. J. Virol. 79, 10103–10107.
    Article CAS PubMed Google Scholar
  19. Li, M., Gao, F., Mascola, J. R., et al. (2005) Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 79, 10108–10125.
    Article CAS PubMed Google Scholar
  20. Li, M., Salazar-Gonzalez, J. F., Derdeyn, C. A., et al. (2006) Genetic and neutralization properties subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in southern Africa.. J. Virol., in press.
    Google Scholar
  21. Brown, B. K., Darden, J. M., Tovanabutra, S., et al. (2005) Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 (HIV-1) isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines. J. Virol. 79, 6089–6101.
    Article CAS PubMed Google Scholar
  22. Esparza, J. and the Coordinating Committee of the Global HIV/AIDS Vaccine Enterprise. (2005) The Global HIV/AIDS Vaccine Enterprise: Scientific strategic plan. PLoS Medicine 2(2), e25.
    Google Scholar
  23. Johnson, V. A., Byington, R. E. (1990) Infectivity assay (virus yield assay), in (Aldovani, A., and Walker, B. D., eds.), Techniques in HIV Research, pp71–76. Stockton Press, New York, N.Y.
    Google Scholar
  24. Montefiori, D. C., Cornell, R. J., Zhou, J. Y., et al. (1994) Complement control proteins, CD46, CD55 and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection. Virology 205, 82–92.
    Article CAS PubMed Google Scholar
  25. Louder, M. K., Sambor, A., Chertova, E., et al. (2005) HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization sensitivity. Virology 339, 226–238.
    Article CAS PubMed Google Scholar

Download references